Multimeric Biotherapeutics, Inc.
October 17, 2023
Franciscan C
Oncology
Multimeric Biotherapeutics, Inc. is an early-stage, founder-backed company focused on stimulating immunity against cancer and infections. Its patented FortiVac technology elicits very strong CD8+ T cell responses that can be directed against cancer and infectious agents.
Company Type
Privately Funded
Website
https://multimericbio.com/
CEO/Top Company Official
Richard S. Kornbluth, MD, PhD
Lead Product in Development
FortiVac vaccine platform technology to elicit CD8+ T cells against cancer and infections.
Number Of Unlicensed Products
1
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)